James J. Collins - Net Worth and Insider Trading

James J. Collins Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James J. Collins owns 3 companies in total, including Fulcrum Therapeutics Inc (FULC) , Orion Biotech Opportunities Corp (ORIA) , and Senti Biosciences Inc (SNTI) .

Click here to see the complete history of James J. Collins’s form 4 insider trades.

Insider Ownership Summary of James J. Collins

Ticker	Comapny	Transaction Date	Type of Owner
FULC	Fulcrum Therapeutics Inc	2020-06-11	director
ORIA	Orion Biotech Opportunities Corp	2021-05-12	director
SNTI	Senti Biosciences Inc	2022-06-08	director

James J. Collins Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James J. Collins Ownership Network

Ownership Network List of James J. Collins

No Data

Ownership Network Relation of James J. Collins

James J. Collins Owned Company Details

What does Fulcrum Therapeutics Inc do?

Who are the key executives at Fulcrum Therapeutics Inc?

James J. Collins is the director of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .

Fulcrum Therapeutics Inc (FULC) Insider Trades Summary

Over the past 18 months, James J. Collins made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net purchase of 4,609,704 shares made by Ra Capital Healthcare Fund Lp , a net sale of 5,330 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .

In summary, during the past 3 months, insiders sold 236 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 236 shares. During the past 18 months, 12,096 shares of Fulcrum Therapeutics Inc (FULC) were sold and 4,653,064 shares were bought by its insiders, resulting in a net purchase of 4,640,968 shares.

Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Fulcrum Therapeutics Inc Insider Transactions

No Available Data

What does Orion Biotech Opportunities Corp do?

Who are the key executives at Orion Biotech Opportunities Corp?

James J. Collins is the director of Orion Biotech Opportunities Corp. Other key executives at Orion Biotech Opportunities Corp include director & Chief Executive Officer James Huang , 10 percent owner Orion Sponsor Holdings, Llc , and Chief Financial Officer Mark Kayal .

Orion Biotech Opportunities Corp (ORIA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Orion Biotech Opportunities Corp (ORIA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orion Biotech Opportunities Corp (ORIA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orion Biotech Opportunities Corp (ORIA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Orion Biotech Opportunities Corp Insider Transactions

No Available Data

What does Senti Biosciences Inc do?

Who are the key executives at Senti Biosciences Inc?

James J. Collins is the director of Senti Biosciences Inc. Other key executives at Senti Biosciences Inc include Chief Medical & Devt. Officer Kanya Rajangam , 10 percent owner Scott D Sandell , and 10 percent owner Bayer Us Holding Lp .

Senti Biosciences Inc (SNTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Senti Biosciences Inc (SNTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Senti Biosciences Inc (SNTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Senti Biosciences Inc (SNTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Senti Biosciences Inc Insider Transactions

No Available Data

James J. Collins Mailing Address

Above is the net worth, insider trading, and ownership report for James J. Collins. You might contact James J. Collins via mailing address: C/o Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge Ma 02139.

Discussions on James J. Collins

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.